The U.S. FDA has updated a policy originally issued on Feb. 29 on diagnostic testing for coronavirus (COVID-19) in order to achieve more rapid testing capacity in the U.S. The policy addresses labs and commercial manufacturers to expand the number and variety of diagnostic tests, as well as available testing capabilities in health care settings, and reference and commercial labs. The FDA is urging state authorities and commercial developers to take all necessary steps to ensure the availabili...